New antidepressant use in older adults: a Canadian population-based study (1997–2013)

References

• Aarts, N., Noordam, R., Hofman, A., Tiemeier, H., Stricker, B.H., & Visser, L.E. (2014). Utilization patterns of antidepressants between 1991 and 2011 in a population-based cohort of middle-aged and elderly. European Psychiatry, 29, 365–370.
   PubMed Web of Science ®Google Scholar
• Aguglia, E., Ravasio, R., & Simonetti, M., Pecchiolic, S., & Mazzolenid, F. (2012). Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003–2009. Current Medical Research and Opinion, 28, 1475–1484.
   PubMed Web of Science ®Google Scholar
• Akincigil, A., Olfson, M., Walkup, J.T., Siegel, M.J., Kalay, E., Amin, S., … Crystal, S. (2011). Diagnosis and treatment of depression in older community-dwelling adults: 1992–2005. Journal of the American Geriatrics Society, 59, 1042–1051.
   PubMed Web of Science ®Google Scholar
• Alexopoulos, G.S., 3, Reynolds, C.F., Bruce, M.L., Katz, I.R., Raue, P.J., … Ten Have, T. (2009). Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. American Journal of the Psychiatry, 166, 882–890.
   PubMed Web of Science ®Google Scholar
• Barry, P.J., Gallagher, P., Ryan, C., & O'mahony, D. (2007). START (Screening Tool to Alert doctors to the Right Treatment) – an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing, 36, 632–638.
   PubMed Web of Science ®Google Scholar
• Blumner, L., & Marcus, S.C. (2009). Changing perceptions of depression: 10-year trends from the general social surveys. Psychological Services, 60, 306–312.
   Google Scholar
• Bolton, J.M., Dahl, M., Sareen, J., Enns, M.W., Leslie, W.D., Collins, D.M., & Alessi-Severini S. (2012). A population-based study of the use of selective serotonin reuptake inhibitors before and after introduction of generic equivalents. Canadian Journal of Psychiatry, 57, 223–229.
   PubMed Web of Science ®Google Scholar
• Cipriani, A., Furukawa, T.A., Salanti, G., Geddes, J.R., Higgins, J.P.T., & Churchill, R, … Barbui, C. (2009). Comparative efficacy and acceptability of 12 new-generation antidepressants: A multi-treatment meta-analysis. Lancet, 373, 746–758.
   PubMed Web of Science ®Google Scholar
• Cyclic Antidepressants. (2012). CPhA Product Monograph. Last updated November 2012. Retrieved May 25, 2015, from http://www.e-therapeutics.ca.
   Google Scholar
• Cymbalta®. (2015). CPhA Product Monograph. Last updated September 17, 2015. Retrieved May 25, 2015, from http://www.e-therapeutics.ca
   Google Scholar
• Deshauer, D. (2007). Venlafaxine (effexor): Concerns about increased risk of fatal outcomes in overdose. CMAJ, 176, 39–40.
   PubMed Web of Science ®Google Scholar
• Fick, D., Semla, T., Beizer, J., Brandt, N., Dombrowski, R., DuBeau, C.E., … Steinman, M., American Geriatrics Society (AGS). (2012). 2012 Beers Criteria Update Expert Panel: American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 60, 616–631.
   Google Scholar
• Gallagher, P., & O'Mahony, D. (2008). STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): Application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing, 37, 673–679.
   PubMed Web of Science ®Google Scholar
• Gelenberg, A.J., Freeman, M.P., Markowitz, J.C., Rosenbaum, J.F., Thase, M.E., Trivedi, M.H., & Van Rhoads, R.S. (2010). Practice guideline for the treatment of patients with major depression disorder, 3rd ed. American Psychiatric Association. November. Retrieved May 25, 2015, from http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf.
   Google Scholar
• Health Canada. (2012). Public communication – health Canada endorsed important safety information on celexa. Last updated January 30,. Retrieved May 25, 2015, from http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/16887a-eng.php.
   Google Scholar
• Health Canada. (2015). Drug product database online query. Last updated July 17,. Retrieved December 22, 2015, from http://webprod5.hc-sc.gc.ca/dpd-bdpp/index-eng.jsp
   Google Scholar
• Hunkeler, E.M., Katon, W., Tang, L., Williams, J.W., Kroenke, K., Lin, E.H.B., … Unutzer, J. (2006). Long term outcomes from the IMPACT randomized trial for depressed patients in primary care. BMJ, 332, 259–263.
   PubMed Web of Science ®Google Scholar
• IMS Health. (2012). Top 20 therapeutic classes by U.S. dispensed prescriptions [IMS Health Web site]. February 3,. Retrieved May 25, 2015, from http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/Press%20Room/Top_line_data/Top_Therapy_Classes_by_RX.pdf
   Google Scholar
• Kessler, R.C., Berglund, P., Demler, O., Jim, R., Koretz, D., Merikangas, K.R., … Wang, P.S. Replication, National Comorbidity Survey. (2003). The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA, 289, 3092–3105.
   Web of Science ®Google Scholar
• Lam, R.W., Kennedy, S., & Grigoriadis, McIntyre, R.S., Milev, R., Ramasubbu, R., … Ravindran, A.V. (2009). Canadian network for mood and anxiety treatments (canmat) clinical guidelines for the management of major depressive disorder in adults. iii. pharmacotherapy. Journal of Affective Disorders, 117, S26–S43.
   PubMed Web of Science ®Google Scholar
• Manitoba Health. (2015). Bulletin #82 Manitoba drug benefits and interchangeability formulary amendments. Last updated April 20,. Retrieved December 22, 2015, from http://webprod5.hc-sc.gc.ca/dpd-bdpp/index-eng.jsp
   Google Scholar
• Marcus, S.C., & Olfson, M. (2010). National trends in the treatment for depression from 1998 to 2007. Archives of General Psychiatry, 67, 1265–1273.
   PubMed Web of Science ®Google Scholar
• Manitoba Health, Health Living and Seniors. (2015). Manitoba pharmacare program. Pharmacare Deductible Estimator. Retrieved January 7, 2016, from http://www.gov.mb.ca/health/pharmacare/estimator.html.
   Google Scholar
• Noordam, R., Aarts, N., & Vernamme, K.M., Sturkenboom, M.C.M., Stricker, B.H., & Visser, L.E. (2015). Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: A dynamic population-based study. European Journal of Clinical Pharmacology, 71, 369–375.
   PubMed Web of Science ®Google Scholar
• Olfson, M., & Marcus, S.C. (2009). National patterns in antidepressant medication treatment. Archives of General Psychiatry, 66, 848–856.
   PubMed Web of Science ®Google Scholar
• Parabiaghi, A., Franchi, C., & Tettamanti, M., Barbato, A., D'Avanzo, B., Fortino, I., … Nobili, A. (2011). Antidepressants utilization among elderly in Lombardy from 2000 to 2007: Dispensing trends and appropriateness. European Journal of Clinical Pharmacology, 67, 1077–1083.
   PubMed Web of Science ®Google Scholar
• Principles of Diagnosis and Management of Anxiety Disorders. (2006). Management of anxiety disorders: Clinical practice guidelines. Canadian Journal of Psychiatry, 51, 9S–22S.
   Google Scholar
• Raymond, C.B., Morgan, S.G., & Caetano, P.A.. (2007). Antidepressant utilization in british columbia from 1996 to 2004: Increasing prevalence but not incidence. Psychiatric Services, 58, 79–84.
   PubMed Web of Science ®Google Scholar
• Reid, R.J., Roos, N.P., MacWilliam, L., Frohlich, N., & Black, C. (2002). Assessing population health care need using a claims-based ACG morbidity measure: A validation analysis in the province of Manitoba. Health Services Research journal, 37, 1345–1364.
   PubMed Web of Science ®Google Scholar
• Remeron®. (2015). CPhA Product Monograph. Last updated March 16, 2015. Retrieved May 25, 2015, from http://www.e-therapeutics.ca
   Google Scholar
• Rojas-Fernandez, C., Thomas, V.S., & Carver, D., & Tonks, R. (1999). Suboptimal use of antidepressants in the elderly: A population-based study in Nova Scotia. Clinical Therapeutics, 22, 1937–1950.
   Web of Science ®Google Scholar
• Ryynanen, O.P., Kivela, S.L., Honkanen, R.., Laippala, P., & Saano, V. (1993). Medications and chronic diseases as risk factors for falling injuries in the elderly. Scandinavian Journal of Social Medicine, 21, 264–271.
   PubMedGoogle Scholar
• Solai, L.K., Mulsant, B.H., & Pollock, B.G. (2001). Selective serotonin reuptake inhibitors for late-life depression: A comparative review. Drugs & Aging, 18, 355–368.
   PubMed Web of Science ®Google Scholar
• Special Populations. (2006). Management of anxiety disorders: Clinical practice guidelines. Canadian Journal of Psychiatry, 51, 65S–72S.
   Google Scholar
• Stone, M., Laughren, T., Jones, M.L., Levenson, M., Holland, P.C., Hammad, T.A., … Rochester, G. (2009). Risk of suicidality in clinical trials of antidepressants in adults: Analysis of proprietary data submitted to US Food and Drug Administration. BMJ, 339, b2880.
   PubMed Web of Science ®Google Scholar
• Trazodone. (2012). CPhA Product Monograph. Last updated November 2012. Retrieved May 25, 2015, from http://www.e-therapeutics.ca.
   Google Scholar
• Turner, E.H., Matthews, A.M., Linardatos, E., Tell, R.A., & Rosenthal, R. (2008). Selective publication of antidepressant effectiveness and its influence on apparent efficacy. The New England Journal of Medicine, 358, 252–260.
   PubMed Web of Science ®Google Scholar
• Unutzer, J., Katon, W., Callahan, C.M., Jr, Williams, J.W., Hunkeler, E., Harpole, L., … Langston, C. (2002). Collaborative care management of late-life depression in the primary care setting: A randomized controlled trial. JAMA, 288, 2836–2845.
   PubMed Web of Science ®Google Scholar
• Weiner, J.P., Starfield, B.H., & Lieberman, R.N. (1992). Johns Hopkins ambulatory care groups (ACGs). A case-mix system for UR, QA and capitation adjustment. HMO Practice, 6, 13–19.
   PubMedGoogle Scholar
• Wyeth Medical Information & Pharmacovigilance. (2004). Important drug safety information for EFFEXOR®: Warning for SSRIs and other newer anti-depressants regarding the potential for behavioural and emotional changes, including risk of self-harm. Last updated January 1, 2004. Retrieved December 22, 2015, from http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2004/14256a-eng.php
   Google Scholar